Concizumab

(Synonyms: NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody)
1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98.12%
  • CAS. Nr.: 1312299-39-0
  • Molecular Weight:146.28 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Concizumab

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00